Enanta Pharmaceuticals Ownership 2024 | Who Owns Enanta Pharmaceuticals Now?
Institutional Ownership
103.93%
Insider Ownership
6.09%
Retail Ownership
-10.02%
Institutional Holders
100.00
Enanta Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 9.89% | 0.13% | 2,095,000 | - | - | 27,172,150 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.13% | 0.00% | 1,934,390 | 6,312 | 0.33% | 25,089,038 | Jun 30, 2024 |
| BLACKROCK INC. | 8.72% | 0.00% | 1,847,519 | 8,464 | 0.46% | 23,962,321 | Jun 30, 2024 |
| MORGAN STANLEY | 6.88% | 0.00% | 1,456,559 | -588,586 | -28.78% | 18,891,574 | Jun 30, 2024 |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 5.91% | 7.45% | 1,251,338 | 126,752 | 11.27% | 16,230,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 5.17% | 0.18% | 1,096,000 | -140,000 | -11.33% | 14,215,120 | Jun 30, 2024 |
| CALIGAN PARTNERS LP | 4.92% | 3.16% | 1,042,889 | 184,819 | 21.54% | 13,526,270 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 4.38% | 0.02% | 928,363 | -22,699 | -2.39% | 12,040,868 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 4.01% | 0.03% | 849,424 | -4,472 | -0.52% | 11,014,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 3.99% | 0.00% | 845,116 | -88,240 | -9.45% | 10,961,155,000 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 3.77% | 0.91% | 799,546 | 219,000 | 37.72% | 10,370,112 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.23% | 0.00% | 683,143 | -23,105 | -3.27% | 8,860,365 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 2.81% | 0.00% | 595,913 | 79,547 | 15.41% | 7,728,992 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.52% | 0.01% | 534,181 | -36,065 | -6.32% | 6,928,328 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.41% | 0.01% | 510,900 | -15,200 | -2.89% | 6,626,373 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.28% | 0.15% | 483,276 | 94,676 | 24.36% | 6,268,090 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.19% | 0.00% | 462,776 | 20,704 | 4.68% | 6,002,891 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.01% | 0.01% | 426,561 | -157,097 | -26.92% | 5,532,496 | Jun 30, 2024 |
| STATE STREET CORP | 2.00% | 0.00% | 422,828 | -1,137 | -0.27% | 5,484,079,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.42% | 0.40% | 300,000 | - | - | 3,891,000 | Jun 30, 2024 |
Enanta Pharmaceuticals's largest institutional shareholder is FARALLON CAPITAL MANAGEMENT LLC, holding 9.89% of the company's total share outstanding, currently valued at $27.17M. The top 10 institutional shareholders own together 63.02% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KRENSAVAGE ASSET MANAGEMENT, LLC | 5.91% | 7.45% | 1,251,338 | 126,752 | 11.27% | 16,230,000 | Jun 30, 2024 |
| CALIGAN PARTNERS LP | 4.92% | 3.16% | 1,042,889 | 184,819 | 21.54% | 13,526,270 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 3.77% | 0.91% | 799,546 | 219,000 | 37.72% | 10,370,112 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.84% | 0.62% | 177,004 | - | - | 2,295,742 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.42% | 0.40% | 300,000 | - | - | 3,891,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 5.17% | 0.18% | 1,096,000 | -140,000 | -11.33% | 14,215,120 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.28% | 0.15% | 483,276 | 94,676 | 24.36% | 6,268,090 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 9.89% | 0.13% | 2,095,000 | - | - | 27,172,150 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.17% | 0.12% | 35,100 | - | - | 455,247 | Jun 30, 2024 |
| PORTLAND GLOBAL ADVISORS LLC | 0.16% | 0.06% | 33,185 | 8,810 | 36.14% | 430,409 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.17% | 0.04% | 36,243 | -3,484 | -8.77% | 470,072 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.07% | 0.04% | 14,326 | -10,884 | -43.17% | 185,809 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 4.01% | 0.03% | 849,424 | -4,472 | -0.52% | 11,014,000 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.22% | 0.03% | 45,999 | 45,999 | 100.00% | 596,607 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.07% | 0.03% | 13,760 | -25 | -0.18% | 178,467 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.05% | 0.02% | 11,588 | 9,692 | 511.18% | 150,296 | Jun 30, 2024 |
| CLEARSTEAD TRUST, LLC | 0.02% | 0.02% | 5,064 | - | - | 65,681 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 4.38% | 0.02% | 928,363 | -22,699 | -2.39% | 12,040,868 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.37% | 0.02% | 78,923 | -16,716 | -17.48% | 1,023,631 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.01% | 0.01% | 426,561 | -157,097 | -26.92% | 5,532,496 | Jun 30, 2024 |
The largest Enanta Pharmaceuticals shareholder by % of total assets is KRENSAVAGE ASSET MANAGEMENT, LLC. The company owns 1.25M shares of Enanta Pharmaceuticals (ENTA), representing 7.45% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 3.77% | 0.91% | 799,546 | 219,000 | 37.72% | 10,370,112 | Jun 30, 2024 |
| CALIGAN PARTNERS LP | 4.92% | 3.16% | 1,042,889 | 184,819 | 21.54% | 13,526,270 | Jun 30, 2024 |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 5.91% | 7.45% | 1,251,338 | 126,752 | 11.27% | 16,230,000 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.28% | 0.15% | 483,276 | 94,676 | 24.36% | 6,268,090 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 2.81% | 0.00% | 595,913 | 79,547 | 15.41% | 7,728,992 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.22% | 0.03% | 45,999 | 45,999 | 100.00% | 596,607 | Jun 30, 2024 |
| NORGES BANK | 0.19% | 0.00% | 40,700 | 40,700 | 100.00% | 527,879 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.11% | 0.00% | 22,349 | 22,349 | 100.00% | 289,867 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.19% | 0.00% | 462,776 | 20,704 | 4.68% | 6,002,891 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.75% | 0.00% | 158,546 | 20,499 | 14.85% | 2,056,341 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.21% | 0.00% | 45,350 | 18,003 | 65.83% | 588,188 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.07% | 0.00% | 15,200 | 15,200 | 100.00% | 197,144 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 10,807 | 10,807 | 100.00% | 140,167 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.16% | 0.00% | 34,758 | 10,075 | 40.82% | 450,811 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 9,762 | 9,762 | 100.00% | 126,613 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.05% | 0.02% | 11,588 | 9,692 | 511.18% | 150,296 | Jun 30, 2024 |
| PORTLAND GLOBAL ADVISORS LLC | 0.16% | 0.06% | 33,185 | 8,810 | 36.14% | 430,409 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.35% | 0.00% | 73,841 | 8,645 | 13.26% | 957,718 | Jun 30, 2024 |
| BLACKROCK INC. | 8.72% | 0.00% | 1,847,519 | 8,464 | 0.46% | 23,962,321 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.13% | 0.00% | 27,892 | 7,287 | 35.37% | 361,759 | Jun 30, 2024 |
As of Jun 30 2024, Enanta Pharmaceuticals's largest institutional buyer is SOLEUS CAPITAL MANAGEMENT, L.P.. The company purchased 219.00K stocks of ENTA, valued at $10.37M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 6.88% | 0.00% | 1,456,559 | -588,586 | -28.78% | 18,891,574 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.01% | 0.01% | 426,561 | -157,097 | -26.92% | 5,532,496 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 5.17% | 0.18% | 1,096,000 | -140,000 | -11.33% | 14,215,120 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 3.99% | 0.00% | 845,116 | -88,240 | -9.45% | 10,961,155,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.87% | 0.01% | 184,557 | -72,752 | -28.27% | 2,393,704 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.61% | 0.00% | 129,062 | -60,194 | -31.81% | 1,673,737 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.28% | 0.00% | 60,005 | -49,701 | -45.30% | 778,265 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -44,629 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.28% | 0.00% | 59,784 | -42,841 | -41.75% | 775,399 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.52% | 0.01% | 534,181 | -36,065 | -6.32% | 6,928,328 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.26% | 0.00% | 55,607 | -33,780 | -37.79% | 721,222 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.23% | 0.00% | 683,143 | -23,105 | -3.27% | 8,860,365 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 4.38% | 0.02% | 928,363 | -22,699 | -2.39% | 12,040,868 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.37% | 0.02% | 78,923 | -16,716 | -17.48% | 1,023,631 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.04% | - | 8,968 | -15,941 | -64.00% | 116,315 | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -15,745 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.34% | 0.00% | 72,925 | -15,230 | -17.28% | 945,834,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.41% | 0.01% | 510,900 | -15,200 | -2.89% | 6,626,373 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.74% | 0.00% | 157,064 | -15,200 | -8.82% | 2,037,120 | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -14,282 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Enanta Pharmaceuticals's biggest institutional seller is MORGAN STANLEY. The company sold -0.59M shares of ENTA, valued at $18.89M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| Y-INTERCEPT (HONG KONG) LTD | 0.22% | 0.03% | 45,999 | 45,999 | 100.00% | 596,607 | Jun 30, 2024 |
| NORGES BANK | 0.19% | 0.00% | 40,700 | 40,700 | 100.00% | 527,879 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 10,807 | 10,807 | 100.00% | 140,167 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 9,762 | 9,762 | 100.00% | 126,613 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 128 | 128 | 100.00% | 1,661 | Jun 30, 2024 |
| PICTON MAHONEY ASSET MANAGEMENT | 0.00% | - | 79 | 79 | 100.00% | 1,000 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 16 | 16 | 100.00% | 208 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 10 | 10 | 100.00% | 130 | Jun 30, 2024 |
Enanta Pharmaceuticals's largest new institutional shareholder by number of shares is Y-INTERCEPT (HONG KONG) LTD, purchased 46.00K shares, valued at $596.61K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -44,629 | -100.00% | - | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -15,745 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -14,282 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -13,689 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -11,333 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -10,927 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -10,405 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -9,985 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -7,574 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -6,781 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,114 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -1,052 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -400 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -333 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -163 | -100.00% | - | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | - | -86 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Enanta Pharmaceuticals's largest sold out institutional shareholder by shares sold is CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD., sold -44.63K shares, valued at -, as of undefined.
Enanta Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| WANGER ADVISORS TRUST | 0.19% | 105,499 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.12% | 382,855 | - | - | Mar 31, 2024 |
| HSBC FUNDS | 0.08% | 2,550 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.05% | 112,311 | 62,108 | 123.71% | Jan 31, 2024 |
| Vanguard Montgomery Funds | 0.04% | 10,112 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.04% | 118,106 | - | - | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.03% | 124,501 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 14,469 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.03% | 88,024 | - | - | Mar 31, 2024 |
| SYNTAX ETF TRUST | 0.02% | 786 | - | - | Mar 31, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.02% | 24,682 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.02% | 487 | - | - | Dec 31, 2023 |
| VANGUARD HORIZON FUNDS | 0.02% | 442,040 | -200,537 | -31.21% | Mar 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.02% | 10,179 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.01% | 3,150 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.01% | 38,941 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.01% | 46,630 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 12,784 | - | - | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.01% | 39,900 | -15,500 | -27.98% | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 18,118 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.01% | 20,508 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 92,701 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 37,581 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 11,733 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 4,187 | 1,112 | 36.16% | Dec 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 253,365 | 32,100 | 14.51% | Mar 31, 2024 |
| RANGER FUNDS INVESTMENT TRUST | 0.00% | 187 | 187 | - | Apr 30, 2020 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.00% | 749 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,739 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.00% | 8,583 | - | - | Jan 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.00% | 19,477 | - | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 9,324 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 648 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 22,260 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.00% | 24,046 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 909,637 | -242,572 | -21.05% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 137,615 | - | - | Feb 29, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 11,052 | - | - | Mar 31, 2020 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 2,823 | - | - | Mar 31, 2024 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 10,400 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 6,270 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 19,604 | 6,450 | 49.03% | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 650 | - | - | Feb 29, 2024 |
| ROYCE VALUE TRUST, INC. | 0.00% | 1,067 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 55,115 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 5,471 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 15,421 | 550 | 3.70% | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 179,273 | 15,532 | 9.49% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 15,695 | 2,195 | 16.26% | Mar 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 172,358 | - | - | Mar 31, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 8,970 | - | - | Dec 31, 2023 |
| Destra Investment Trust | 0.00% | 1,239 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,973 | - | - | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 5,339 | -960 | -15.24% | Dec 31, 2023 |
| SHELTON FUNDS | 0.00% | 1,144 | - | - | Feb 29, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 8,869 | -331 | -3.60% | Mar 31, 2023 |
| TARGET PORTFOLIO TRUST | 0.00% | 13,900 | 13,900 | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 19,541 | -2,675 | -12.04% | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 5,700 | -1,300 | -18.57% | Mar 28, 2024 |
| Direxion Shares ETF Trust | 0.00% | 89,325 | - | - | Jan 31, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 1,260 | - | - | Jan 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 982 | - | - | Mar 31, 2024 |
| FundVantage Trust | 0.00% | 7,152 | - | - | Mar 28, 2024 |
| AMG FUNDS III | 0.00% | 2,288 | - | - | Mar 28, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 12,654 | 12,254 | 3063.50% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 11,703 | -968 | -7.64% | Mar 31, 2024 |
| TIMOTHY PLAN | 0.00% | 1,782 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 6,712 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 157 | - | - | Apr 30, 2021 |
| Catholic Responsible Investments Funds | 0.00% | 11,375 | - | - | Jan 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 22,593 | - | - | Mar 28, 2024 |
| VANGUARD WORLD FUND | 0.00% | 67,718 | 352 | 0.52% | Feb 29, 2024 |
| Ultimus Managers Trust | 0.00% | 3,021 | - | - | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 13,188 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 2,938 | -89 | -2.94% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 1,515 | - | - | Aug 31, 2023 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 3,770 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 9,220 | - | - | Jan 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 144 | - | - | Sep 30, 2023 |
| Amplify ETF Trust | 0.00% | 5,444 | 5,444 | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 105,621 | 2,812 | 2.74% | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 785 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 862 | -262 | -23.31% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 3,463 | - | - | Mar 31, 2024 |
| Guggenheim Variable Funds Trust | 0.00% | 684 | - | - | Dec 31, 2023 |
| Voya INVESTORS TRUST | 0.00% | 8,793 | -651 | -6.89% | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 2,100 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 3,517 | 423 | 13.67% | Mar 31, 2024 |
| KP Funds | 0.00% | 6,361 | 500 | 8.53% | Sep 30, 2020 |
| Meeder Funds | 0.00% | 643 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 17,283 | -59,564 | -77.51% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 55,420 | 11,717 | 26.81% | Jan 31, 2024 |
| North Square Investments Trust | 0.00% | 1,190 | - | - | Jan 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 3,932 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 9,635 | 12 | 0.12% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 301 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 9,896 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 453 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 12,115 | 3,878 | 47.08% | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 419 | - | - | Mar 28, 2024 |
Enanta Pharmaceuticals's largest mutual fund holder by % of total assets is "WANGER ADVISORS TRUST", owning 105.50K shares, compromising 0.19% of its total assets.
Enanta Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 100 | -6.54% |
| 31 Mar, 24 | 107 | 1.90% |
| 31 Dec, 23 | 105 | -19.85% |
| 30 Sep, 23 | 131 | -1.50% |
| 30 Jun, 23 | 133 | -8.90% |
| 31 Mar, 23 | 146 | -2.01% |
| 31 Dec, 22 | 149 | -7.45% |
| 30 Sep, 22 | 161 | 4.55% |
| 30 Jun, 22 | 154 | -9.41% |
| 31 Mar, 22 | 170 | -7.61% |
| 31 Dec, 21 | 184 | 24.32% |
| 30 Sep, 21 | 148 | -2.63% |
| 30 Jun, 21 | 152 | - |
| 31 Mar, 21 | 152 | -0.65% |
| 31 Dec, 20 | 153 | -10.53% |
| 30 Sep, 20 | 171 | -6.04% |
| 30 Jun, 20 | 182 | 14.47% |
| 31 Mar, 20 | 159 | -10.67% |
| 31 Dec, 19 | 178 | -2.73% |
| 30 Sep, 19 | 183 | -8.50% |
| 30 Jun, 19 | 200 | -1.96% |
| 31 Mar, 19 | 204 | 9.68% |
| 31 Dec, 18 | 186 | -7.92% |
| 30 Sep, 18 | 202 | 2.02% |
| 30 Jun, 18 | 198 | 7.03% |
| 31 Mar, 18 | 185 | 27.59% |
| 31 Dec, 17 | 145 | 15.08% |
| 30 Sep, 17 | 126 | 2.44% |
| 30 Jun, 17 | 123 | -3.15% |
| 31 Mar, 17 | 127 | -15.33% |
| 31 Dec, 16 | 150 | 7.91% |
| 30 Sep, 16 | 139 | 6.11% |
| 30 Jun, 16 | 131 | -15.48% |
| 31 Mar, 16 | 155 | 11.51% |
| 31 Dec, 15 | 139 | -4.79% |
| 30 Sep, 15 | 146 | 11.45% |
| 30 Jun, 15 | 131 | 10.08% |
| 31 Mar, 15 | 119 | -5.56% |
| 31 Dec, 14 | 126 | 12.50% |
| 30 Sep, 14 | 112 | 13.13% |
| 30 Jun, 14 | 99 | 25.32% |
| 31 Mar, 14 | 79 | 19.70% |
| 31 Dec, 13 | 66 | 32.00% |
| 30 Sep, 13 | 50 | 31.58% |
| 30 Jun, 13 | 38 | 1800.00% |
| 31 Mar, 13 | 2 | - |
As of 30 Jun 24, 100 institutions are holding Enanta Pharmaceuticals's shares, representing a decrease of -6.54% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 22,011,926 | -1.25% |
| 31 Mar, 24 | 22,290,570 | 11.98% |
| 31 Dec, 23 | 19,906,154 | -1.08% |
| 30 Sep, 23 | 20,122,617 | -0.08% |
| 30 Jun, 23 | 20,138,509 | 1.66% |
| 31 Mar, 23 | 19,809,160 | 3.51% |
| 31 Dec, 22 | 19,137,917 | -2.51% |
| 30 Sep, 22 | 19,630,222 | -2.61% |
| 30 Jun, 22 | 20,157,288 | 2.90% |
| 31 Mar, 22 | 19,589,692 | 4.25% |
| 31 Dec, 21 | 18,790,590 | -3.12% |
| 30 Sep, 21 | 19,395,886 | 3.07% |
| 30 Jun, 21 | 18,818,368 | -3.14% |
| 31 Mar, 21 | 19,427,575 | 0.86% |
| 31 Dec, 20 | 19,262,796 | 2.37% |
| 30 Sep, 20 | 18,816,279 | 3.14% |
| 30 Jun, 20 | 18,243,882 | 1.28% |
| 31 Mar, 20 | 18,013,637 | -2.10% |
| 31 Dec, 19 | 18,400,344 | 2.90% |
| 30 Sep, 19 | 17,881,711 | 0.19% |
| 30 Jun, 19 | 17,848,097 | 0.29% |
| 31 Mar, 19 | 17,795,800 | 5.67% |
| 31 Dec, 18 | 16,840,455 | 1.33% |
| 30 Sep, 18 | 16,619,624 | 10.20% |
| 30 Jun, 18 | 15,081,026 | 2.33% |
| 31 Mar, 18 | 14,737,342 | 4.99% |
| 31 Dec, 17 | 14,036,678 | 9.84% |
| 30 Sep, 17 | 12,778,665 | 1.31% |
| 30 Jun, 17 | 12,613,241 | -1.80% |
| 31 Mar, 17 | 12,844,587 | -3.69% |
| 31 Dec, 16 | 13,336,201 | 1.61% |
| 30 Sep, 16 | 13,124,768 | -2.24% |
| 30 Jun, 16 | 13,425,834 | -5.74% |
| 31 Mar, 16 | 14,242,727 | -2.63% |
| 31 Dec, 15 | 14,627,002 | -31.98% |
| 30 Sep, 15 | 21,504,930 | 55.74% |
| 30 Jun, 15 | 13,808,377 | 11.22% |
| 31 Mar, 15 | 12,415,626 | 18.83% |
| 31 Dec, 14 | 10,448,196 | 4.36% |
| 30 Sep, 14 | 10,012,089 | 3.58% |
| 30 Jun, 14 | 9,666,034 | 14.56% |
| 31 Mar, 14 | 8,437,175 | 75.23% |
| 31 Dec, 13 | 4,814,819 | 30.39% |
| 30 Sep, 13 | 3,692,741 | 11.97% |
| 30 Jun, 13 | 3,297,828 | 1033.27% |
| 31 Mar, 13 | 291,000 | - |
Enanta Pharmaceuticals (ENTA) has 22.01M shares outstanding as of 30 Jun 24, down -1.25% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 103.93% | 0.94% |
| 31 Mar, 24 | 105.31% | 1.18% |
| 31 Dec, 23 | 94.40% | 1.03% |
| 30 Sep, 23 | 95.96% | 1.05% |
| 30 Jun, 23 | 95.65% | 1.08% |
| 31 Mar, 23 | 94.17% | 1.11% |
| 31 Dec, 22 | 91.94% | 1.01% |
| 30 Sep, 22 | 95.28% | 1.01% |
| 30 Jun, 22 | 97.33% | 1.07% |
| 31 Mar, 22 | 95.32% | 1.12% |
| 31 Dec, 21 | 92.16% | 1.00% |
| 30 Sep, 21 | 96.13% | 1.11% |
| 30 Jun, 21 | 93.21% | 1.00% |
| 31 Mar, 21 | 96.31% | 1.05% |
| 31 Dec, 20 | 95.87% | 1.08% |
| 30 Sep, 20 | 94.36% | 1.14% |
| 30 Jun, 20 | 91.13% | 1.11% |
| 31 Mar, 20 | 90.42% | 1.04% |
| 31 Dec, 19 | 93.16% | 1.13% |
| 30 Sep, 19 | 90.83% | 1.10% |
| 30 Jun, 19 | 90.72% | 1.09% |
| 31 Mar, 19 | 91.03% | 1.21% |
| 31 Dec, 18 | 86.69% | 1.18% |
| 30 Sep, 18 | 85.76% | 1.40% |
| 30 Jun, 18 | 78.13% | 1.33% |
| 31 Mar, 18 | 76.73% | 1.43% |
| 31 Dec, 17 | 73.38% | 1.64% |
| 30 Sep, 17 | 66.91% | 1.53% |
| 30 Jun, 17 | 66.10% | 1.45% |
| 31 Mar, 17 | 67.44% | 1.37% |
| 31 Dec, 16 | 70.05% | 1.46% |
| 30 Sep, 16 | 69.34% | 1.39% |
| 30 Jun, 16 | 70.73% | 1.16% |
| 31 Mar, 16 | 77.92% | 1.28% |
| 31 Dec, 15 | 77.90% | 0.59% |
| 30 Sep, 15 | 115.17% | 2.11% |
| 30 Jun, 15 | 73.85% | 1.67% |
| 31 Mar, 15 | 66.47% | 2.11% |
| 31 Dec, 14 | 56.16% | 1.89% |
| 30 Sep, 14 | 54.55% | 2.00% |
| 30 Jun, 14 | 52.17% | 2.47% |
| 31 Mar, 14 | 45.97% | 6.35% |
| 31 Dec, 13 | 26.90% | 6.32% |
| 30 Sep, 13 | 20.63% | 6.08% |
| 30 Jun, 13 | 18.42% | 697.27% |
| 31 Mar, 13 | 1.63% | - |
As of 30 Jun 24, Enanta Pharmaceuticals is held by 103.93% institutional shareholders, representing a 0.94% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | 4.76% |
| 31 Mar, 24 | 42 | -22.22% |
| 31 Dec, 23 | 54 | -22.86% |
| 30 Sep, 23 | 70 | -9.09% |
| 30 Jun, 23 | 77 | 45.28% |
| 31 Mar, 23 | 53 | -19.70% |
| 31 Dec, 22 | 66 | -19.51% |
| 30 Sep, 22 | 82 | 22.39% |
| 30 Jun, 22 | 67 | -16.25% |
| 31 Mar, 22 | 80 | -26.61% |
| 31 Dec, 21 | 109 | 101.85% |
| 30 Sep, 21 | 54 | -16.92% |
| 30 Jun, 21 | 65 | -4.41% |
| 31 Mar, 21 | 68 | 4.62% |
| 31 Dec, 20 | 65 | -28.57% |
| 30 Sep, 20 | 91 | -10.78% |
| 30 Jun, 20 | 102 | 27.50% |
| 31 Mar, 20 | 80 | -9.09% |
| 31 Dec, 19 | 88 | -9.28% |
| 30 Sep, 19 | 97 | -8.49% |
| 30 Jun, 19 | 106 | 6.00% |
| 31 Mar, 19 | 100 | 3.09% |
| 31 Dec, 18 | 97 | -14.16% |
| 30 Sep, 18 | 113 | 7.62% |
| 30 Jun, 18 | 105 | -2.78% |
| 31 Mar, 18 | 108 | 27.06% |
| 31 Dec, 17 | 85 | 21.43% |
| 30 Sep, 17 | 70 | 37.25% |
| 30 Jun, 17 | 51 | -15.00% |
| 31 Mar, 17 | 60 | -31.82% |
| 31 Dec, 16 | 88 | 12.82% |
| 30 Sep, 16 | 78 | 25.81% |
| 30 Jun, 16 | 62 | -38.00% |
| 31 Mar, 16 | 100 | 36.99% |
| 31 Dec, 15 | 73 | -23.96% |
| 30 Sep, 15 | 96 | 10.34% |
| 30 Jun, 15 | 87 | 10.13% |
| 31 Mar, 15 | 79 | 12.86% |
| 31 Dec, 14 | 70 | - |
| 30 Sep, 14 | 70 | -2.78% |
| 30 Jun, 14 | 72 | 35.85% |
| 31 Mar, 14 | 53 | 32.50% |
| 31 Dec, 13 | 40 | 21.21% |
| 30 Sep, 13 | 33 | -13.16% |
| 30 Jun, 13 | 38 | 1800.00% |
| 31 Mar, 13 | 2 | - |
44 institutional shareholders have increased their position in ENTA stock as of 30 Jun 24 compared to 42 in the previous quarter (a 4.76% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | -12.00% |
| 31 Mar, 24 | 50 | 16.28% |
| 31 Dec, 23 | 43 | -2.27% |
| 30 Sep, 23 | 44 | 29.41% |
| 30 Jun, 23 | 34 | -48.48% |
| 31 Mar, 23 | 66 | 32.00% |
| 31 Dec, 22 | 50 | - |
| 30 Sep, 22 | 50 | -10.71% |
| 30 Jun, 22 | 56 | -13.85% |
| 31 Mar, 22 | 65 | 30.00% |
| 31 Dec, 21 | 50 | -28.57% |
| 30 Sep, 21 | 70 | 20.69% |
| 30 Jun, 21 | 58 | 1.75% |
| 31 Mar, 21 | 57 | -6.56% |
| 31 Dec, 20 | 61 | 12.96% |
| 30 Sep, 20 | 54 | 3.85% |
| 30 Jun, 20 | 52 | 6.12% |
| 31 Mar, 20 | 49 | -23.44% |
| 31 Dec, 19 | 64 | 20.75% |
| 30 Sep, 19 | 53 | -5.36% |
| 30 Jun, 19 | 56 | -6.67% |
| 31 Mar, 19 | 60 | 7.14% |
| 31 Dec, 18 | 56 | -6.67% |
| 30 Sep, 18 | 60 | 3.45% |
| 30 Jun, 18 | 58 | 9.43% |
| 31 Mar, 18 | 53 | 26.19% |
| 31 Dec, 17 | 42 | 16.67% |
| 30 Sep, 17 | 36 | -18.18% |
| 30 Jun, 17 | 44 | -12.00% |
| 31 Mar, 17 | 50 | 21.95% |
| 31 Dec, 16 | 41 | 7.89% |
| 30 Sep, 16 | 38 | -20.83% |
| 30 Jun, 16 | 48 | 50.00% |
| 31 Mar, 16 | 32 | -21.95% |
| 31 Dec, 15 | 41 | 32.26% |
| 30 Sep, 15 | 31 | 19.23% |
| 30 Jun, 15 | 26 | -10.34% |
| 31 Mar, 15 | 29 | -30.95% |
| 31 Dec, 14 | 42 | 44.83% |
| 30 Sep, 14 | 29 | 31.82% |
| 30 Jun, 14 | 22 | 10.00% |
| 31 Mar, 14 | 20 | -9.09% |
| 31 Dec, 13 | 22 | 69.23% |
| 30 Sep, 13 | 13 | - |
| 30 Jun, 13 | - | - |
| 31 Mar, 13 | - | - |
44 institutional shareholders have reduced their position in ENTA stock as of 30 Jun 24 compared to 50 in the previous quarter (a -12.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 100 | -6.54% | 22,011,926 | -1.25% | 103.93% | 0.94% | 44 | 4.76% | 44 | -12.00% |
| 31 Mar, 24 | 107 | 1.90% | 22,290,570 | 11.98% | 105.31% | 1.18% | 42 | -22.22% | 50 | 16.28% |
| 31 Dec, 23 | 105 | -19.85% | 19,906,154 | -1.08% | 94.40% | 1.03% | 54 | -22.86% | 43 | -2.27% |
| 30 Sep, 23 | 131 | -1.50% | 20,122,617 | -0.08% | 95.96% | 1.05% | 70 | -9.09% | 44 | 29.41% |
| 30 Jun, 23 | 133 | -8.90% | 20,138,509 | 1.66% | 95.65% | 1.08% | 77 | 45.28% | 34 | -48.48% |
| 31 Mar, 23 | 146 | -2.01% | 19,809,160 | 3.51% | 94.17% | 1.11% | 53 | -19.70% | 66 | 32.00% |
| 31 Dec, 22 | 149 | -7.45% | 19,137,917 | -2.51% | 91.94% | 1.01% | 66 | -19.51% | 50 | - |
| 30 Sep, 22 | 161 | 4.55% | 19,630,222 | -2.61% | 95.28% | 1.01% | 82 | 22.39% | 50 | -10.71% |
| 30 Jun, 22 | 154 | -9.41% | 20,157,288 | 2.90% | 97.33% | 1.07% | 67 | -16.25% | 56 | -13.85% |
| 31 Mar, 22 | 170 | -7.61% | 19,589,692 | 4.25% | 95.32% | 1.12% | 80 | -26.61% | 65 | 30.00% |
| 31 Dec, 21 | 184 | 24.32% | 18,790,590 | -3.12% | 92.16% | 1.00% | 109 | 101.85% | 50 | -28.57% |
| 30 Sep, 21 | 148 | -2.63% | 19,395,886 | 3.07% | 96.13% | 1.11% | 54 | -16.92% | 70 | 20.69% |
| 30 Jun, 21 | 152 | - | 18,818,368 | -3.14% | 93.21% | 1.00% | 65 | -4.41% | 58 | 1.75% |
| 31 Mar, 21 | 152 | -0.65% | 19,427,575 | 0.86% | 96.31% | 1.05% | 68 | 4.62% | 57 | -6.56% |
| 31 Dec, 20 | 153 | -10.53% | 19,262,796 | 2.37% | 95.87% | 1.08% | 65 | -28.57% | 61 | 12.96% |
| 30 Sep, 20 | 171 | -6.04% | 18,816,279 | 3.14% | 94.36% | 1.14% | 91 | -10.78% | 54 | 3.85% |
| 30 Jun, 20 | 182 | 14.47% | 18,243,882 | 1.28% | 91.13% | 1.11% | 102 | 27.50% | 52 | 6.12% |
| 31 Mar, 20 | 159 | -10.67% | 18,013,637 | -2.10% | 90.42% | 1.04% | 80 | -9.09% | 49 | -23.44% |
| 31 Dec, 19 | 178 | -2.73% | 18,400,344 | 2.90% | 93.16% | 1.13% | 88 | -9.28% | 64 | 20.75% |
| 30 Sep, 19 | 183 | -8.50% | 17,881,711 | 0.19% | 90.83% | 1.10% | 97 | -8.49% | 53 | -5.36% |
| 30 Jun, 19 | 200 | -1.96% | 17,848,097 | 0.29% | 90.72% | 1.09% | 106 | 6.00% | 56 | -6.67% |
| 31 Mar, 19 | 204 | 9.68% | 17,795,800 | 5.67% | 91.03% | 1.21% | 100 | 3.09% | 60 | 7.14% |
| 31 Dec, 18 | 186 | -7.92% | 16,840,455 | 1.33% | 86.69% | 1.18% | 97 | -14.16% | 56 | -6.67% |
| 30 Sep, 18 | 202 | 2.02% | 16,619,624 | 10.20% | 85.76% | 1.40% | 113 | 7.62% | 60 | 3.45% |
| 30 Jun, 18 | 198 | 7.03% | 15,081,026 | 2.33% | 78.13% | 1.33% | 105 | -2.78% | 58 | 9.43% |
| 31 Mar, 18 | 185 | 27.59% | 14,737,342 | 4.99% | 76.73% | 1.43% | 108 | 27.06% | 53 | 26.19% |
| 31 Dec, 17 | 145 | 15.08% | 14,036,678 | 9.84% | 73.38% | 1.64% | 85 | 21.43% | 42 | 16.67% |
| 30 Sep, 17 | 126 | 2.44% | 12,778,665 | 1.31% | 66.91% | 1.53% | 70 | 37.25% | 36 | -18.18% |
| 30 Jun, 17 | 123 | -3.15% | 12,613,241 | -1.80% | 66.10% | 1.45% | 51 | -15.00% | 44 | -12.00% |
| 31 Mar, 17 | 127 | -15.33% | 12,844,587 | -3.69% | 67.44% | 1.37% | 60 | -31.82% | 50 | 21.95% |
| 31 Dec, 16 | 150 | 7.91% | 13,336,201 | 1.61% | 70.05% | 1.46% | 88 | 12.82% | 41 | 7.89% |
| 30 Sep, 16 | 139 | 6.11% | 13,124,768 | -2.24% | 69.34% | 1.39% | 78 | 25.81% | 38 | -20.83% |
| 30 Jun, 16 | 131 | -15.48% | 13,425,834 | -5.74% | 70.73% | 1.16% | 62 | -38.00% | 48 | 50.00% |
| 31 Mar, 16 | 155 | 11.51% | 14,242,727 | -2.63% | 77.92% | 1.28% | 100 | 36.99% | 32 | -21.95% |
| 31 Dec, 15 | 139 | -4.79% | 14,627,002 | -31.98% | 77.90% | 0.59% | 73 | -23.96% | 41 | 32.26% |
| 30 Sep, 15 | 146 | 11.45% | 21,504,930 | 55.74% | 115.17% | 2.11% | 96 | 10.34% | 31 | 19.23% |
| 30 Jun, 15 | 131 | 10.08% | 13,808,377 | 11.22% | 73.85% | 1.67% | 87 | 10.13% | 26 | -10.34% |
| 31 Mar, 15 | 119 | -5.56% | 12,415,626 | 18.83% | 66.47% | 2.11% | 79 | 12.86% | 29 | -30.95% |
| 31 Dec, 14 | 126 | 12.50% | 10,448,196 | 4.36% | 56.16% | 1.89% | 70 | - | 42 | 44.83% |
| 30 Sep, 14 | 112 | 13.13% | 10,012,089 | 3.58% | 54.55% | 2.00% | 70 | -2.78% | 29 | 31.82% |
| 30 Jun, 14 | 99 | 25.32% | 9,666,034 | 14.56% | 52.17% | 2.47% | 72 | 35.85% | 22 | 10.00% |
| 31 Mar, 14 | 79 | 19.70% | 8,437,175 | 75.23% | 45.97% | 6.35% | 53 | 32.50% | 20 | -9.09% |
| 31 Dec, 13 | 66 | 32.00% | 4,814,819 | 30.39% | 26.90% | 6.32% | 40 | 21.21% | 22 | 69.23% |
| 30 Sep, 13 | 50 | 31.58% | 3,692,741 | 11.97% | 20.63% | 6.08% | 33 | -13.16% | 13 | - |
| 30 Jun, 13 | 38 | 1800.00% | 3,297,828 | 1033.27% | 18.42% | 697.27% | 38 | 1800.00% | - | - |
| 31 Mar, 13 | 2 | - | 291,000 | - | 1.63% | - | 2 | - | - | - |
Enanta Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Enanta Pharmaceuticals's stock was made by Rottinghaus Scott T. on Aug 09 2024, selling 1,467 shares at $17.23 per share (valued at $25.28K).
Enanta Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 5 | 20.00% |
| Q2 2024 | 1 | 1 | 100.00% |
| Q1 2024 | 14 | 8 | 175.00% |
| Q4 2023 | 7 | 14 | 50.00% |
| Q3 2023 | - | 1 | - |
| Q2 2023 | 1 | 1 | 100.00% |
| Q1 2023 | 25 | 21 | 119.05% |
| Q4 2022 | 18 | 13 | 138.46% |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 6 | 13 | 46.15% |
| Q1 2022 | 29 | 17 | 170.59% |
| Q4 2021 | 19 | 22 | 86.36% |
| Q3 2021 | 1 | 1 | 100.00% |
| Q1 2021 | 9 | 3 | 300.00% |
| Q4 2020 | 18 | 12 | 150.00% |
| Q3 2020 | 1 | 1 | 100.00% |
| Q2 2020 | 2 | 1 | 200.00% |
| Q1 2020 | 16 | 8 | 200.00% |
| Q4 2019 | 12 | 12 | 100.00% |
| Q3 2019 | 1 | 1 | 100.00% |
1 total buy trades, and 5 total sell trades (buy/sell ratio of 0.20%) were made by Enanta Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | 8 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 9 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 6 | - |
| Q1 2022 | - | 5 | - |
| Q4 2021 | - | 12 | - |
| Q3 2021 | - | 1 | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | 2 | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Enanta Pharmaceuticals's stocks.
Enanta Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| IKNA | Ikena Oncology, Inc. |
| MRUS | Merus N.V. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| INBX | Inhibrx Biosciences, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| KRON | Kronos Bio, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
ENTA Ownership FAQ
Who Owns Enanta Pharmaceuticals?
Enanta Pharmaceuticals is owned by institutional shareholders (103.93%), insiders (6.09%), and public (-10.02%). The largest institutional shareholder of Enanta Pharmaceuticals is FARALLON CAPITAL MANAGEMENT LLC (9.89% of total shares) and the top mutual fund owner is WANGER ADVISORS TRUST (0.19% of total shares).
Who are the major institutional shareholders of Enanta Pharmaceuticals?
Enanta Pharmaceuticals's major institutional shareholders are FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BLACKROCK INC., MORGAN STANLEY, and KRENSAVAGE ASSET MANAGEMENT, LLC. The top five shareholders own together 40.53% of the company's share outstanding.
How many Enanta Pharmaceuticals shareholders are there?
As of Jun 2024, there are 100 institutional shareholders of Enanta Pharmaceuticals.
What percentage of Enanta Pharmaceuticals is owned by FARALLON CAPITAL MANAGEMENT LLC?
FARALLON CAPITAL MANAGEMENT LLC owns 2.1M shares of Enanta Pharmaceuticals, representing 9.89% of the company's total shares outstanding, valued at $27.17M (as of Jun 2024).
What percentage of Enanta Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 1.93M shares of Enanta Pharmaceuticals (ENTA), compromising 9.13% of the company, valued at $25.09M.
What percentage of Enanta Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Enanta Pharmaceuticals. The company owns 1.85M of the company's shares outstanding (worth $23.96M).